Dimitriou H, Stiakaki E, Markaki E A, Bolonaki I, Giannakopoulou C, Kalmanti M
Department of Pediatric Hematology/Oncology, University Hospital of Heraklion, Crete, Greece.
Acta Paediatr. 2000 Oct;89(10):1169-73. doi: 10.1080/080352500750027510.
Soluble transferrin receptor (sTfR) is a new diagnostic tool for determining iron status and erythropoietic activity. The increased concentrations of sTfR in patients with iron deficiency reflect the hyperplasia of erythroid precursors. The objective of this study was to evaluate sTfR and sTfR/log ferritin index (sTfR-F) values in healthy children (n = 64), full-term neonates (n = 18), children with iron deficiency (n = 16), hemolytic anemia (n = 7), beta-thalassemia traits (n = 18), respiratory infections (n = 41) and malignancies (n = 13), and to compare these parameters for the different subgroups with those of healthy children. The sTfR levels were increased in children with iron deficiency in the same way as in adults (p < 0.0001) and in cases of increased erythropoietic activity, such as during the neonatal period (p < 0.0001), and of hemolytic anemias (p = 0.006). The index was significantly increased in iron deficiency (p < 0.0001) and decreased in neonates (p = 0.011). Children carriers of beta-thalassemia were found to have increased sTfR values (p = 0.015), but not sTfR/log ferritin index (p = 0.491), a finding suggesting that use of both parameters is necessary for distinguishing between those with and those without iron deficiency. In children with upper respiratory infection, the sTfR levels were close to normal, while the index was found to be low. In order to evaluate the iron status in infections, we further subdivided the children into two groups according to the value of ferritin, with the cut-off point at 35 microg/L. Children with ferritin level above 35 microg/L experienced normal sTfR levels but very low index, a finding which could enable the use of these two parameters for distinguishing patients with infection without concomitant iron deficiency. In the group of malignancies under chemotherapy both indices were low (p = 0.005, p < 0.0001) mainly due to myelosuppression.
The interpretation of both sTfR and sTfR/log ferritin index is useful in the evaluation of iron status and erythropoietic activity, especially in children with heterozygous beta-thalassemia, infection and malignancies.
可溶性转铁蛋白受体(sTfR)是一种用于确定铁状态和红细胞生成活性的新型诊断工具。缺铁患者中sTfR浓度升高反映了红系前体细胞的增生。本研究的目的是评估健康儿童(n = 64)、足月新生儿(n = 18)、缺铁儿童(n = 16)、溶血性贫血儿童(n = 7)、β地中海贫血特征儿童(n = 18)、呼吸道感染儿童(n = 41)和恶性肿瘤儿童(n = 13)的sTfR和sTfR/铁蛋白对数指数(sTfR-F)值,并将这些不同亚组的参数与健康儿童的参数进行比较。缺铁儿童的sTfR水平与成人一样升高(p < 0.0001),在红细胞生成活性增加的情况下,如新生儿期(p < 0.0001)和溶血性贫血时(p = 0.006)也是如此。该指数在缺铁时显著升高(p < 0.0001),在新生儿中降低(p = 0.011)。发现β地中海贫血携带者儿童的sTfR值升高(p = 0.015),但sTfR/铁蛋白对数指数未升高(p = 0.491),这一发现表明使用这两个参数对于区分缺铁和非缺铁者是必要的。在上呼吸道感染儿童中,sTfR水平接近正常,而该指数较低。为了评估感染时的铁状态,我们根据铁蛋白值将儿童进一步分为两组,临界值为35μg/L。铁蛋白水平高于35μg/L的儿童sTfR水平正常但指数极低,这一发现使得可以使用这两个参数来区分无合并缺铁的感染患者。在接受化疗的恶性肿瘤组中,两个指数均较低(p = 0.005,p < 0.0001),主要是由于骨髓抑制。
sTfR和sTfR/铁蛋白对数指数的解读对于评估铁状态和红细胞生成活性是有用的,尤其是在杂合子β地中海贫血、感染和恶性肿瘤儿童中。